What Rams news: PED allegations involve ElAttrache, Ty Simpson?
Rams news: PED allegations involving Dr. Neal ElAttrache and unsigned rookie Ty Simpson have emerged. They have thrust the team into a complex off-field drama. The allegations tie a long-time Rams surgeon to a Major League Baseball probe. Meanwhile, contract talks leave rookie quarterback Ty Simpson unsigned as the club balances roster priorities. Fans and analysts are watching closely.
This introduction outlines the controversy and the stakes. However, the probe centers on claims that a consultant prescribed banned medication after surgery. The NFL has not yet commented publicly. ElAttrache denies direct involvement with the prescription. The investigation could affect the Rams’ ties with him.
In addition, the team faces urgent roster decisions. Because only two first-round picks remain unsigned, the Rams must weigh paying Simpson against other needs. Therefore, this article will walk through the allegations and the available evidence. It will also examine roster scenarios for Ty Simpson in the coming weeks.
Rams news: PED allegations involving Dr. Neal ElAttrache and unsigned rookie Ty Simpson
Overview
Major League Baseball opened an inquiry after reporting linked Dr. Neal ElAttrache to claims about performance-enhancing drugs. The claims involve treatment given to Conor McGregor after a severe leg fracture. However, the situation remains complex and not all details are public. The New York Times first reported parts of the story, and the NFL has not yet issued a formal comment.
What MLB is investigating
- Allegation: a consultant prescribed banned medication after surgery overseen by ElAttrache.
- Timeline: McGregor suffered two broken bones in his lower left leg during a 2021 UFC bout.
- Actions under review: whether ElAttrache supported or facilitated the use of prohibited substances.
Because the probe involves prescription practices, MLB focused on medical records and communications. Therefore, investigators are seeking clarity on who recommended and prescribed the medications. As a result, the exact role played by each medical professional matters to the inquiry.
ElAttrache’s response and medical background
Dr. ElAttrache has publicly denied direct involvement with the consultant’s prescription. He said, “I purposely wasn’t involved with his evaluation by the consultant nor with prescribing medication.” He also pointed to his long track record with elite athletes. For example, he has treated professional baseball players like Shohei Ohtani and high profile figures such as Arnold Schwarzenegger. In addition, he has maintained a two decade relationship with the Los Angeles Rams and is often mentioned as a close associate of Tom Brady.
Why this matters to the Rams
- Reputation: ElAttrache’s ties to the Rams could complicate the team’s medical credibility.
- Relationship risk: the organization may reassess its working relationship while the probe continues.
- Timing: this story comes as the team negotiates rookie contracts and adjusts the roster.
In short, the allegations are serious and multifaceted. However, investigators still need to establish direct links and motives. Therefore readers should expect updates as official findings and responses emerge.
Roster comparison: Ty Simpson vs Fernando Mendoza
Below is a quick comparison of the two unsigned rookies. It highlights draft status, expected role, contract talks, and team strategy.
| Category | Ty Simpson | Fernando Mendoza |
|---|---|---|
| Draft status |
|
|
| Expected role |
|
|
| Contract negotiation |
|
|
| Team strategy |
|
|
| Timeline and outlook |
|
|
Roster pressure amid Rams news: PED allegations involving Dr. Neal ElAttrache and unsigned rookie Ty Simpson
Stafford extension
Extending Matthew Stafford locks in the veteran starter and reduces the urgency to force a rookie into the lineup. Consequently the club can prioritize short term stability, which shifts available rookie funds toward other needs.
Myles Garrett acquisition
Adding Myles Garrett signals a win now approach and increases immediate salary commitments. As a result the front office faces tighter cap choices that could pressure rookie contract flexibility.
Exploration of veteran targets
The team is exploring veteran receivers and complementary pieces to boost the offense. Those pursuits compete directly with draft signings for cap space and roster spots, potentially delaying rookie deals.
Unsigned rookies and cap flexibility
Both Ty Simpson and Fernando Mendoza remain unsigned while the team balances priorities. Mendoza offers near term starter value while Simpson is being viewed as a development project, making his signing timeline more contingent on other moves.
Impact on Ty Simpson and next steps
Together these moves make Simpson more likely to start the season as a backup and to accept a value oriented rookie deal. Monitor veteran signings and cap adjustments, since their resolution will determine Simpson’s contract timing and the Rams long term development plan.
Conclusion
Rams news: PED allegations involving Dr. Neal ElAttrache and unsigned rookie Ty Simpson have introduced new uncertainty for the franchise. MLB is investigating claims tied to treatment given to Conor McGregor, while ElAttrache denies direct involvement. The inquiry could affect the Rams due to his long association with the team and with high profile athletes.
At the same time, roster decisions remain urgent. The Rams extended Matthew Stafford, acquired Myles Garrett, and may pursue veteran additions like Stefon Diggs. Because cap space and priorities shifted, Ty Simpson’s rookie deal faces added pressure and may wait until the team finalizes veteran moves.
Official responses remain limited, and the NFL has not publicly commented. Therefore, conclusions remain premature. Readers should expect evolving reporting as MLB continues its probe and as the Rams close more roster deals.
We will track official findings and contract developments carefully. For cautious, fact based coverage and timely updates, follow Rams News LLC at Rams News LLC and on Twitter/X @ZachGatsby. Stay tuned for updates as new information emerges.
Frequently Asked Questions (FAQs)
What are the core allegations in this story?
Major League Baseball is probing claims connected to Dr. Neal ElAttrache. Investigators focus on treatment given to Conor McGregor after his 2021 leg fracture. Reports say a consultant prescribed banned medication after surgery overseen by ElAttrache. ElAttrache has denied direct involvement with the prescription. However, the inquiry remains active and details may change.
Is the Rams organization itself under investigation?
No public evidence shows the Rams face a formal investigation. MLB’s probe centers on medical conduct tied to McGregor. The NFL has not publicly commented on the matter. Nevertheless, the Rams may reassess their relationship with ElAttrache while officials investigate. Therefore club ties could change depending on findings.
Could this affect the team’s medical staff or reputation?
Yes, potentially. Because ElAttrache holds a long association with the Rams, the probe could raise reputational concerns. The organization may review policies and outside relationships. As a result, the team could pause or alter its use of outside consultants. However, no official changes have been announced so far.
Why does Ty Simpson remain unsigned, and how do roster moves influence his status?
Ty Simpson remains unsigned as the Rams finalize broader roster and cap plans. The team extended Matthew Stafford and added Myles Garrett, which shifted salary priorities. The club is also exploring veteran targets like Stefon Diggs. Because of those moves, Simpson’s rookie deal faces added scrutiny and timing pressure. Meanwhile Fernando Mendoza appears likelier to sign sooner and earn early playing time.
What should readers watch for next?
Watch for official statements from MLB, the Rams, or the NFL. Also follow contract updates for Simpson and Mendoza. Monitor any veteran signings that affect cap space. For accurate, cautious updates, expect more reporting as investigators and team officials release information.


